HHS underwent a sweeping restructuring this week, resulting in about 10,000 layoffs across various agencies. With critical ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.

All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA ...

Winning the talent war requires more than just competitive salaries. Fair compensation is essential, but today’s workforce craves a culture that recognizes them as whole people with vibrant ...

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...

Now that AI tools are everywhere, the question making headlines is whether businesses will see substantial returns from their AI investments. The answer for health plans is a definite yes.

With substance use disorders continuing to contribute significantly to morbidity and mortality worldwide, innovative financial strategies have emerged as powerful levers to bridge the gap between ...